Study of a High-Risk Group of Stage II Colon Cancer

被引:0
|
作者
Hirosawa, Tomoichiro [1 ]
Itabashi, Michio [1 ]
Bamba, Yoshiko [1 ]
Ogawa, Shinpei [1 ]
Sirotani, Noriyasu [1 ]
Kameoka, Shingo [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Surg 2, Sch Med, Sinjuku Ku, Tokyo 1628666, Japan
关键词
Colon cancer; Stage II; Adjuvant chemotherapy; RECTAL-CANCER; EFFICACY; FLUOROURACIL; TRIAL;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study was conducted for the purpose of identifying a high-risk group for recurrence of stage II colon cancer and determine those cases for which postoperative adjuvant chemotherapy for stage II colon cancer is indicated. The subjects of this study consisted of 179 stage II cases and 114 stage IIIa cases among 462 surgical colon cancer cases examined at this department from January 1, 1991 to December 31, 1996 classified as A for the degree of cure, with the exception of m cancer. A nonrecurrence group and a recurrence group of stage II and stage IIIa colon cancer cases were compared on the basis of parameters. Gender, age, and lymph ducts were extracted from multivariate analysis, while age and lymph ducts were extracted from a survival analysis using the Cox proportional hazard model. A high-risk group for recurrence of stage II colon cancer was determined to consist of young men of ly 2.3. Since the nonrecurrence survival rates and survival prognoses of ly 2.3 cases in particular were equivalent to those of stage IIIa, this is considered to be a risk factor for recurrence of stage II colon cancer, and postoperative chemotherapy is believed to be indicated.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 50 条
  • [21] Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
    Cakar, B.
    Varol, U.
    Junushova, B.
    Muslu, U.
    Oner, P. Gursoy
    Surmeli, Z. Gokhan
    Cirak, Y.
    Karaca, B.
    Sezgin, C.
    Karabulut, B.
    Uslu, R.
    JOURNAL OF BUON, 2013, 18 (02): : 372 - 376
  • [22] High-risk groups of patients with stage II colon carcinoma
    Merkel, S
    Wein, A
    Günther, K
    Papadopoulos, T
    Hohenberger, W
    Hermanek, P
    CANCER, 2001, 92 (06) : 1435 - 1443
  • [23] Tumor budding as an index to identify high-risk patients with stage II colon cancer
    Nakamura, Takatoshi
    Mitomi, Hiroyuki
    Kanazawa, Hideki
    Ohkura, Yasuo
    Watanabe, Masahiko
    DISEASES OF THE COLON & RECTUM, 2008, 51 (05) : 568 - 572
  • [24] The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer
    Sada, Yvonne
    Duan, Zhigang
    El-Serag, Hashem
    Davila, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [25] A retrospective study based on SEER database: not all high-risk factors are equal for stage II colon cancer
    Li, Dong
    Jiang, Zongze
    Xian, Lili
    Yang, Chuanhua
    Long, Feiwu
    Liu, Wenneng
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (04) : 689 - 698
  • [26] Risk factors for recurrence in patients with high-risk stage II colon cancer after curative resection
    Ohge, H.
    Sadahiro, S.
    Sakamoto, K.
    Tsuchiya, T.
    Takahashi, T.
    Sato, T.
    Kondo, K.
    Ogata, Y.
    Baba, H.
    Itabashi, M.
    Ikeda, M.
    Hamada, M.
    Kusano, M.
    Hyodo, I.
    Sakamoto, J.
    Taguri, M.
    Morita, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S417 - S417
  • [27] Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer
    Yang, Lujing
    Chen, Pengju
    Zhang, Li
    Wang, Lin
    Sun, Tingting
    Zhou, Lixin
    Li, Zhongwu
    Wu, Aiwen
    BRITISH JOURNAL OF CANCER, 2020, 123 (06) : 973 - 981
  • [28] Adjuvant Chemotherapy in High-risk Stage II Colon Cancer Patients: (Un) common Practice?
    Koebrugge, B.
    Van Steenbergen, L. N.
    Lips, D. J.
    Lemmens, V. E.
    Van der Linden, H. C.
    Pruijt, H. F.
    Liefers, G.
    Van de Velde, C. J.
    Bosscha, K.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S103 - S103
  • [29] Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
    Cho, Jung Rae
    Lee, Keun-Wook
    Oh, Heung-Kwon
    Kim, Jin Won
    Kim, Ji-Won
    Kim, Duck-Woo
    Kim, Jee Hyun
    Kang, Sung-Bum
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2022, 102 (05) : 271 - 280
  • [30] Elevated Carcinoembryonic Antigen Warrants Adjuvant Chemotherapy in High-risk Stage II Colon Cancer
    Wilson, Tanner B.
    Narayanan, Sowmya
    Khan, Sidrah
    Althans, Alison R.
    Paniccia, Alessandro
    Zureikat, Amer H.
    Kaltenmeier, Christof
    Lee, Kenneth K.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 380 - 380